119 related articles for article (PubMed ID: 21644919)
1. Antistaphylococcal activity of novel salicylanilide derivatives.
Mollaghan A; Vinsova J; Imramovsky A; Cotter L; Lucey B; O'Mahony J; Costelloe A; Coffey A
Curr Drug Discov Technol; 2012 Mar; 9(1):39-47. PubMed ID: 21644919
[TBL] [Abstract][Full Text] [Related]
2. Antimycobacterial activity of salicylanilide benzenesulfonates.
Krátký M; Vinšová J; Rodriguez NG; Stolaříková J
Molecules; 2012 Jan; 17(1):492-503. PubMed ID: 22222908
[TBL] [Abstract][Full Text] [Related]
3. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
[TBL] [Abstract][Full Text] [Related]
4. In vitro antibacterial and antifungal activity of salicylanilide benzoates.
Krátký M; Vinšová J; Buchta V
ScientificWorldJournal; 2012; 2012():290628. PubMed ID: 22666101
[TBL] [Abstract][Full Text] [Related]
5. Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
Krátký M; Vinšová J
Bioorg Med Chem; 2016 Mar; 24(6):1322-30. PubMed ID: 26879856
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of salicylanilide 4-(trifluoromethyl)-benzoates.
Krátký M; Vinšová J; Novotná E; Mandíková J; Trejtnar F; Stolaková J
Molecules; 2013 Mar; 18(4):3674-88. PubMed ID: 23529028
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial and antifungal activity of salicylanilide pyrazine-2-carboxylates.
Krátký M; Vinšová J; Buchta V
Med Chem; 2012 Jul; 8(4):732-41. PubMed ID: 22548336
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial effect and toxicity of synthesized salicylanilide derivatives.
Ghazi IM; Mohamed ZA; Ismail SA; Kamal A
Zentralbl Mikrobiol; 1986; 141(3):225-32. PubMed ID: 3094282
[TBL] [Abstract][Full Text] [Related]
9. Salicylanilide acetates: synthesis and antibacterial evaluation.
Vinsova J; Imramovsky A; Buchta V; Ceckova M; Dolezal M; Staud F; Jampilek J; Kaustova J
Molecules; 2007 Jan; 12(1):1-12. PubMed ID: 17693949
[TBL] [Abstract][Full Text] [Related]
10. Salicylanilide carbamates: Promising antibacterial agents with high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA).
Zadrazilova I; Pospisilova S; Masarikova M; Imramovsky A; Ferriz JM; Vinsova J; Cizek A; Jampilek J
Eur J Pharm Sci; 2015 Sep; 77():197-207. PubMed ID: 26079401
[TBL] [Abstract][Full Text] [Related]
11. Study of Biological Activities and ADMET-Related Properties of Salicylanilide-Based Peptidomimetics.
Pindjakova D; Pilarova E; Pauk K; Michnova H; Hosek J; Magar P; Cizek A; Imramovsky A; Jampilek J
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232947
[TBL] [Abstract][Full Text] [Related]
12. Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: pharmacophore identification based on the screening hit closantel.
Hlasta DJ; Demers JP; Foleno BD; Fraga-Spano SA; Guan J; Hilliard JJ; Macielag MJ; Ohemeng KA; Sheppard CM; Sui Z; Webb GC; Weidner-Wells MA; Werblood H; Barrett JF
Bioorg Med Chem Lett; 1998 Jul; 8(14):1923-8. PubMed ID: 9873460
[TBL] [Abstract][Full Text] [Related]
13. Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase.
Krátký M; Vinšová J; Novotná E; Mandíková J; Wsól V; Trejtnar F; Ulmann V; Stolaříková J; Fernandes S; Bhat S; Liu JO
Tuberculosis (Edinb); 2012 Sep; 92(5):434-9. PubMed ID: 22765970
[TBL] [Abstract][Full Text] [Related]
14. Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
Vinšová J; Kozic J; Krátký M; Stolaříková J; Mandíková J; Trejtnar F; Buchta V
Bioorg Med Chem; 2014 Jan; 22(2):728-37. PubMed ID: 24369840
[TBL] [Abstract][Full Text] [Related]
15. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
Macielag MJ; Demers JP; Fraga-Spano SA; Hlasta DJ; Johnson SG; Kanojia RM; Russell RK; Sui Z; Weidner-Wells MA; Werblood H; Foleno BD; Goldschmidt RM; Loeloff MJ; Webb GC; Barrett JF
J Med Chem; 1998 Jul; 41(16):2939-45. PubMed ID: 9685233
[TBL] [Abstract][Full Text] [Related]
16. New amino acid esters of salicylanilides active against MDR-TB and other microbes.
Krátký M; Vinšová J; Buchta V; Horvati K; Bösze S; Stolaříková J
Eur J Med Chem; 2010 Dec; 45(12):6106-13. PubMed ID: 20937542
[TBL] [Abstract][Full Text] [Related]
17. The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
Zhang WM; Yao Y; Yang T; Wang XY; Zhu ZY; Xu WT; Lin HX; Gao ZB; Zhou H; Yang CG; Cui YM
Bioorg Med Chem Lett; 2018 Jun; 28(10):1943-1948. PubMed ID: 29650291
[TBL] [Abstract][Full Text] [Related]
18. Salicylanilide ester prodrugs as potential antimicrobial agents--a review.
Krátký M; Vinsová J
Curr Pharm Des; 2011; 17(32):3494-505. PubMed ID: 22074422
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
20. The relationship between structure and in vitro antistaphylococcal effect of plant-derived stilbenes.
Zakova T; Rondevaldova J; Bernardos A; Landa P; Kokoska L
Acta Microbiol Immunol Hung; 2018 Dec; 65(4):467-476. PubMed ID: 30203690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
